Structure Therapeutics Inc. American Depositary Shares (GPCR · NASDAQ)
GPCR · MARKET VIEW
Market view · as of Jul 27, 2026
Revenue (TTM)
$0
0.0% YoY
EPS (latest q)
$-0.35
vs $-0.33 est · miss
52-wk position
42.4%
-47.6% vs 52w high · +1.8% 1mo
Price (last ~year)
Clinical-stage biopharmaceutical firm Structure Therapeutics (GPCR) faces a patent dispute concerning its oral GLP-1 weight-loss drug compounds. The company, which maintains a $3.49 billion market capitalization, reported $0 revenue and a $76.2 million net loss for the quarter ending March 31, 2026. With $316.2 million in cash and $5.8 million in total debt, shares closed at $49.12, down 3.3% on the day.
Valuation
- Market cap
- $3.49B
- P/B
- 2.413
- EV/EBITDA
- -13.46
- Beta
- -1.569
- Analyst target
- $104.83
Quality & returns
- Operating margin
- 0.0%
- Profit margin
- 0.0%
- ROE
- -15.0%
- ROA
- -11.6%
Price movement
- Last
- $49.12
- 1-month
- +1.8%
- 3-month
- +12.8%
- RSI (14)
- 37
- vs SMA200
- -4.6%
- 52-wk position
- 42.4% -47.6% vs high
Quarterly trajectory
Revenue by quarter (oldest → newest)
| Quarter | Revenue | Op income | Net income | EBITDA |
|---|---|---|---|---|
| 2026-03-31 | $0 | $-89.6M | $-76.2M | $-74.8M |
| 2025-12-31 | $0 | $24.0M | $33.0M | $33.6M |
| 2025-09-30 | $0 | $-73.8M | $-65.7M | $-65.3M |
| 2025-06-30 | $0 | $-70.5M | $-61.7M | $-61.2M |
Recent news
- Bullish Structure Therapeutics Inc (GPCR) Institutional Confidence · 2026-07-26
- Bearish Form 4 Structure Therapeutics Inc ADR For: 24 July By Investing.com · 2026-07-25
- Somewhat-Bearish GPCR|Structure Therapeutics Inc|Price:49.120|Chg%:-1.680 · 2026-07-25
- Somewhat-Bullish GPCR|Structure Therapeutics Inc|Price:49.120|Chg%:-1.680 · 2026-07-25
- Bearish Form 4 Structure Therapeutics Inc ADR For: 24 July By Investing.com · 2026-07-24
- Somewhat-Bullish Patent fight erupts around next generation of multibillion-dollar GLP-1 weight-loss drugs · 2026-07-24
Sources this view read
- fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
- filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
- earnings Reported earnings history (Alpha Vantage EARNINGS)
- prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)